日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cortical bone properties in the Brtl/+ mouse model of Osteogenesis imperfecta as evidenced by acoustic transmission microscopy

通过声透射显微镜观察成骨不全症Brtl/+小鼠模型的皮质骨特性

Blouin, S; Fratzl-Zelman, N; Roschger, A; Cabral, W A; Klaushofer, K; Marini, J C; Fratzl, P; Roschger, P

Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization team

分层色谱生物分析方法性能评价方法:全球生物分析联盟协调团队提出的最佳实践和协调建议

Lowes, S; Hucker, R; Jemal, M; Marini, J C; Rezende, V M; Shoup, R; Singhal, P; Timmerman, P; Yoneyama, T; Weng, N; Zimmer, D

Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix

非致死性隐性成骨不全症中 CRTAP 缺乏会导致胶原蛋白沉积到基质中减少。

Valli, M; Barnes, A M; Gallanti, A; Cabral, W A; Viglio, S; Weis, M A; Makareeva, E; Eyre, D; Leikin, S; Antoniazzi, F; Marini, J C; Mottes, M

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.

强直性脊柱炎患者接受英夫利昔单抗治疗后的炎症生物标志物、疾病活动度和脊柱疾病指标

Visvanathan S, Wagner C, Marini J C, Baker D, Gathany T, Han J, van der Heijde D, Braun J

Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis

成骨不全症中I型胶原蛋白的生化筛选:检测α链氨基末端的甘氨酸取代需要分子分析的补充。

Cabral, W A; Milgrom, S; Letocha, A D; Moriarty, E; Marini, J C

Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders

反义寡脱氧核苷酸选择性抑制IV型成骨不全成纤维细胞中突变型α2(I)胶原等位基因的表达。显性负性疾病的分子治疗策略

Wang, Q; Marini, J C